Cell contamination assay
AssigneeSistemic Scotland Ltd
InventorsDavid Mallinson, Elaine Gourlay, James Reid, Ditte Andersen
Life of this patent
Estimating the term…
Loading patent…
AssigneeSistemic Scotland Ltd
InventorsDavid Mallinson, Elaine Gourlay, James Reid, Ditte Andersen
Estimating the term…
A method for determining the presence and level of PSC contaminants in a PSC-derived cell population for use in cell therapy by assaying a sample of the PSC-derived cell population against a panel of non-coding RNAs such as miRNA known to be differentially expressed in PSC contaminants, thereby detecting residual PSC cell contamination at a level of 10 and even 5 or fewer residual contaminating PSC cells in a background of one million cells, such that a PSC-derived cell population or sample may be identified as meeting safety requirements for use in cell therapy.
A method for determining the presence and/or level of contamination by pluripotent stem cell (PSC) contaminants in a PSC-derived cell population for further use, the method comprising
A method of producing a pluripotent stem cell (PSC)-derived cell population for use in cell therapy, the method comprising:
Dependencies are inferred from the claim text.